Dual-Organoid Biosensor for Monitoring2 Cardiac Conduction Disturbances In Vitro

Investor logo

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

SVĚRÁK Filip KABANOV Daniil VRANA Šimon BECKEROVÁ Deborah MÁCHAL Jan PEŠL Martin ROTREKL Vladimír PŘIBYL Jan

Year of publication 2025
Type Article in Periodical
Magazine / Source Analytica Chimica Acta
MU Faculty or unit

Faculty of Medicine

Citation
web https://www.sciencedirect.com/science/article/pii/S0003267025012681
Doi https://doi.org/10.1016/j.aca.2025.344874
Keywords Cellular biosensor;atomic force microscopy;arrhythmia;cardiomyocytes;drug screening;drug cardiotoxicity;conduction;pluripotent stem cells;biomechanical properties.
Attached files
Description Accurate detection of conduction disorders, a critical factor for arrhythmogenic risk assessment, is a key challenge in drug development and cardiovascular safety screening. This study presents a highly sensitive atomic force microscopy (AFM)-based biosensor using a dual-beating human pluripotent stem cell (hPSC)-derived organoid to discriminate between focal and conductive arrhythmic contractions. Analysis of the variance of the regression residuals revealed increased stochastic (random) fluctuations in unsynchronized clusters, indicative of arrhythmic instability. Mechanosensing assessed by force microscopy allows the differentiation of the vertical and lateral direction of contractile movement. The high biosensor sensitivity allowed detailed analysis of contractile behavior under pharmacological modulation with cardiomodulating drugs. Moreover, heptanol-induced arrhythmias were associated with inhibition of atrioventricular conduction, demonstrating the ability of the system to model mechanisms of conduction blockade. For the first time, an AFM-based transducer successfully discriminates focal from conductive arrhythmias, marking a significant advance in in vitro cardiac biosensing. The dual organoid system enhances model robustness by reducing the variability inherent in single-cell studies, thereby improving translational relevance for cardiotoxicity assessment and precision medicine applications in cardiovascular health
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info